๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic potential of soluble guanylate cyclase agonists in pulmonary hypertension

โœ Scribed by Oleg V Evgenov; Daniel S Kohane; Warren M Zapol


Publisher
BioMed Central
Year
2007
Tongue
English
Weight
181 KB
Volume
7
Category
Article
ISSN
1471-2210

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


BAY 63โ€“2521, an oral soluble guanylate c
โœ Ardeschir Hossein Ghofrani; Gerrit Weimann; Reiner Frey; Robert Voswinckel; Mela ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› BioMed Central ๐ŸŒ English โš– 410 KB

Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.

The soluble guanylate cyclase stimulator
โœ Michaela Lang; Baktybek Kojonazarov; Norbert Weissmann; Friedrich Grimminger; Jo ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› BioMed Central ๐ŸŒ English โš– 136 KB

Lang et al.: The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats. BMC Pharmacology 2011 11(Suppl 1):P43.

Heterogeneous distribution of soluble gu
โœ D'Angelis, Christopher A. ;Nickerson, Peter A. ;Steinhorn, Robin H. ;Morin III, ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 146 KB ๐Ÿ‘ 1 views

Background: Vascular segments in the fetal lung differ anatomically and functionally from one another. At birth, the nitric oxide (NO) pathway plays an integral role in reducing pulmonary vascular resistance through a marked vasodilation. However, the contributions of each vascular segment to this d